急诊环境下抗凝药管理:2024年法国急诊医学会(SFMU)、法国麻醉与重症医学会(SFAR)、法国血栓与止血学会(SFTH)及法国围术期止血工作组(GIHP)指南,获法国神经血管学会认可
法国急诊医学会(SFMU)、法国麻醉与重症医学会(SFAR)、法国围术期止血工作组(GIHP)和法国血栓与止血学会(SFTH)联合召集法国和比利时专家,采用GRADE方法制定急诊环境下抗凝药管理指南。工作组确定5个领域:实验室检测在确定抗凝药使用及抗凝水平中的作用、抗凝药相关出血的管理、无症状过量的管理、抗凝状态下非择期侵入性操作的管理、抗凝状态下急性缺血性卒中溶栓。基于PICO模型提出问题,自1990年起按PRISMA推荐进行广泛文献检索,数据质量用GRADE方法分析,推荐采用GRADE方法制定并经GRADE网格法全体专家投票。最终形成103条推荐、涉及21个问题,经两轮投票和多次修订后97条达成强烈共识,其中19条为GRADE 1(高证据水平)、35条为GRADE 2(低证据水平)、48条为专家意见,另有1个问题未能形成推荐。
要点
- 指南覆盖5大领域:实验室检测抗凝水平、抗凝相关出血、无症状过量、抗凝下非择期侵入性操作、抗凝下急性缺血性卒中溶栓。
- 103条推荐中19条为GRADE 1(高证据水平)、35条为GRADE 2(低证据水平)、48条为专家意见,1个问题未能形成推荐。
- 证据检索自1990年起按PRISMA推荐进行,数据质量用GRADE方法分析,推荐经GRADE网格法全体专家投票。
- 经两轮投票和多次修订后,97条推荐达成强烈共识。
- 专家组声明利益冲突在推荐制定过程开始时正式申报,制定过程独立于任何产业资助。
适用人群与场景
- 急诊环境下正在使用抗凝药的患者,涵盖抗凝药相关出血、无症状过量、需非择期侵入性操作及急性缺血性卒中溶栓等场景。
研究设计与关键结果
- 指南由SFMU、SFAR、GIHP和SFTH联合召集法国和比利时专家制定,采用GRADE方法评估文献证据水平,覆盖5个领域、21个PICO问题。
- 最终形成103条推荐,经两轮投票和多次修订后97条达成强烈共识;其中19条为GRADE 1、35条为GRADE 2、48条为专家意见;1个问题未能形成推荐。
证据类型、等级与局限
- 证据类型:指南,采用GRADE方法进行证据分级,推荐经GRADE网格法全体专家投票。
- 推荐强度分布:19条GRADE 1、35条GRADE 2、48条专家意见。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- Anticoagulant management in Emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP), endorsed by the French Neurovascular Society.
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The Société Française de Médecine d'Urgence (SFMU), the Société Française d'Anesthésie et de Réanimation (SFAR), the Groupe d'Intérêt en Hémostase Péri-opératoire (GIHP) and the Société Française de Thrombose et d'Hémostase (SFHT) have collaborated to propose a set of guidelines on the management of anticoagulants in an emergency setting.
DESIGN: A group of French and Belgian experts from the French Societies of Emergency Medicine (SFMU), Anaesthesia and Intensive Care (SFAR), the working group on Perioperative Haemostasis (GIHP) and the French Society of Thrombosis and Haemostasis (SFHT) was convened. Any potential conflicts of interest were officially declared at the start of the recommendation development process, which was conducted independently of any industry funding. The authors used the GRADE ("Grading of Recommendations Assessment, Development and Evaluation") methodology to assess the level of evidence in the literature.
METHODS: Five areas were defined: (1) The role of laboratory testing in determining anticoagulant use and the level of anticoagulation; (2) Management of anticoagulant-associated bleeding; (3) Management of asymptomatic overdoses; (4) Management of non-elective invasive procedures on anticoagulants; and (5) Thrombolysis for acute ischaemic stroke on anticoagulants. For each field, the aim of the recommendations was to answer a certain number of questions formulated by the experts according to the PICO model ("Population, Intervention, Comparison, Outcome"). Based on these questions, an extensive bibliographic search from 1990 onwards was carried out using predefined key words according to the PRISMA recommendations. Data quality was analysed using the GRADE method. Recommendations were formulated using the GRADE method and then voted on by all the experts using the GRADE grid method.
RESULTS: The experts' summary work and application of the GRADE method resulted in 103 recommendations concerning 21 questions. After two rounds of voting and several amendments, strong agreement was reached on 97 recommendations. Out of these recommendations, 19 have a high level of evidence (19 GRADE 1), 35 have a low level of evidence (35 GRADE 2), and 48 are expert opinions. Finally, for one question, no recommendation could be made.
CONCLUSIONS: There was strong agreement among the experts to provide recommendations for clinicians to provide up-to-date management of patients on anticoagulants in an emergency setting.
参考来源
- Douillet D, Godon A, Rousseau G, et al. Anticoagulant management in Emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP), endorsed by the French Neurovascular Society. Anaesth Crit Care Pain Med. 2025. PMID: 40581261. doi:10.1016/j.accpm.2025.101584
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。